NDLI: Mouse models of pancreatic cancer

Content Provider	PubMed Central
Author	Marta, Herreros-villanueva Elizabeth, Hijona Cosme, Angel Bujanda, Luis
Copyright Year	2012
Abstract	Pancreatic cancer is one of the most lethal of human malignancies ranking 4th among cancer-related death in the western world and in the United States, and potent therapeutic options are lacking. Although during the last few years there have been important advances in the understanding of the molecular events responsible for the development of pancreatic cancer, currently specific mechanisms of treatment resistance remain poorly understood and new effective systemic drugs need to be developed and probed. In vivo models to study pancreatic cancer and approach this issue remain limited and present different molecular features that must be considered in the studies depending on the purpose to fit special research themes. In the last few years, several genetically engineered mouse models of pancreatic exocrine neoplasia have been developed. These models mimic the disease as they reproduce genetic alterations implicated in the progression of pancreatic cancer. Genetic alterations such as activating mutations in KRas, or TGFb and/or inactivation of tumoral suppressors such as p53, INK4A/ARF BRCA2 and Smad4 are the most common drivers to pancreatic carcinogenesis and have been used to create transgenic mice. These mouse models have a spectrum of pathologic changes, from pancreatic intraepithelial neoplasia to lesions that progress histologically culminating in fully invasive and metastatic disease and represent the most useful preclinical model system. These models can characterize the cellular and molecular pathology of pancreatic neoplasia and cancer and constitute the best tool to investigate new therapeutic approaches, chemopreventive and/or anticancer treatments. Here, we review and update the current mouse models that reproduce different stages of human pancreatic ductal adenocarcinoma and will have clinical relevance in future pancreatic cancer developments.
Related Links	http://dx.doi.org/10.3748/wjg.v18.i12.1286
Starting Page	1286
File Format	PDF
ISSN	10079327
Journal	World Journal of Gastroenterology : WJG
Issue Number	12
Volume Number	18
Language	English
Publisher	Baishideng Publishing Group Co., Limited
Publisher Date	2012-01-01
Access Restriction	Open
Rights Holder	Baishideng Publishing Group Co., Limited
Subject Keyword	Gastroenterology Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Gastroenterology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models

Endogenous Opioids Inhibit Early Stage Pancreatic Pain in a Mouse Model of Pancreatic Cancer

Generation and characterization of a transgenic mouse model for pancreatic cancer

Microencapsulated tumor assay: Evaluation of the nude mouse model of pancreatic cancer

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

Genetically Engineered Mouse Models of Pancreatic Cancer

Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies

Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer

Mouse models for the discovery of colorectal cancer driver genes

Mouse models of pancreatic cancer

Similar Documents

Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models

Endogenous Opioids Inhibit Early Stage Pancreatic Pain in a Mouse Model of Pancreatic Cancer

Generation and characterization of a transgenic mouse model for pancreatic cancer

Microencapsulated tumor assay: Evaluation of the nude mouse model of pancreatic cancer

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

Genetically Engineered Mouse Models of Pancreatic Cancer

Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies

Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer

Mouse models for the discovery of colorectal cancer driver genes

Mouse models of pancreatic cancer